“Founded in 1995, QPS is a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development. We provide quality services to pharmaceutical and biotechnology clients worldwide. Our linearly integrated core competencies include: Neuropharmacology, DMPK, Toxicology, Bioanalysis, Translational Medicine, Early Stage Clinical Research, Phase II-IV Clinical Research, Program Management. QPS' experience and expertise in every stage of CNS drug development, enable us to navigate our clients toward successful and timely approval of their CNS therapeutics, whether these are small molecules, biologics or medical devices.”